Head to head
Acadia Healthcare vs HCA Healthcare
Side-by-side on the measures that matter, with a plain-English read. Full detail: ACHC · HCA
ACHC
Acadia Healthcare
29.23+0.65%
1-year price shape — +7% over the period
Quant Rating C · 52/100
vs
HCA
HCA Healthcare
439.17+1.61%
1-year price shape — +1% over the period
Quant Rating D · 41/100
1-year performance, rebased to 100
HCA Healthcare edges it on the scoreable measures. HCA Healthcare pays the highest dividend yield; HCA Healthcare earns the most per share.
| ACHC | HCA | |
|---|---|---|
| Snapshot | ||
| Sector | Medical Care Facilities | -- |
| Last price | 29.23 | 439.17 |
| Change today | +0.65% | +1.61% |
| 1-year return | +7.3% | +0.9% |
| Market cap | $2.72B | $95.08B |
| 52-week range | 11.43 – 35.83 | 353.34 – 553.56 |
| Valuation | ||
| P/E (TTM) | -2.35 | 14.73 |
| P/E percentile, own 5-yr range | 31st | 55th |
| P/B | 1.38 | -14.32 |
| Dividend yield | 0.00% | 0.68% |
| Profitability & growth | ||
| EPS (TTM) | -12.16 | 28.33 |
| Net profit (TTM) | $-1.13B | $6.13B |
| Revenue (TTM) | $3.37B | $78.01B |
| Revenue growth (YoY) | -0.4% | +8.7% |
| Gross margin | 96.4% | 42.6% |
| Operating margin | 10.1% | 15.5% |
| Net margin | -33.4% | 8.8% |
| Free cash flow (TTM) | $-134.03M | $6.00B |
| Ownership & sentiment | ||
| Institutional ownership | 144.3% | 94.6% |
| Insider activity (12mo) | 31 buy / 14 sell | 22 buy / 23 sell |
| Short interest (% of float) | 23.1% | 3.0% |
| Analyst consensus | 64% buy / 27% hold / 9% sell (11) | 64% buy / 32% hold / 5% sell (22) |
| Analyst price target | $37 (+25%) | $457 (+4%) |
| StockVane view | ||
| StockVane Quant Rating | C (52) | D (41) |
| Company | ||
| Employees | 25,000 | 320,000 |
| Founded | 2005 | 1968 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.